218 related articles for article (PubMed ID: 15580302)
21. A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1.
Rozenfeld-Granot G; Krishnamurthy J; Kannan K; Toren A; Amariglio N; Givol D; Rechavi G
Oncogene; 2002 Feb; 21(10):1469-76. PubMed ID: 11896574
[TBL] [Abstract][Full Text] [Related]
22. Multiple response elements and differential p53 binding control Perp expression during apoptosis.
Reczek EE; Flores ER; Tsay AS; Attardi LD; Jacks T
Mol Cancer Res; 2003 Dec; 1(14):1048-57. PubMed ID: 14707288
[TBL] [Abstract][Full Text] [Related]
23. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
24. p53 status affects the rate of the onset but not the overall extent of doxorubicin-induced cell death in rat-1 fibroblasts constitutively expressing c-Myc.
Han JW; Dionne CA; Kedersha NL; Goldmacher VS
Cancer Res; 1997 Jan; 57(1):176-82. PubMed ID: 8988061
[TBL] [Abstract][Full Text] [Related]
25. AMID is a p53-inducible gene downregulated in tumors.
Wu M; Xu LG; Su T; Tian Y; Zhai Z; Shu HB
Oncogene; 2004 Sep; 23(40):6815-9. PubMed ID: 15273740
[TBL] [Abstract][Full Text] [Related]
26. PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression.
Yin Y; Liu YX; Jin YJ; Hall EJ; Barrett JC
Nature; 2003 Apr; 422(6931):527-31. PubMed ID: 12673251
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin by p53-dependent apoptosis.
Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
Acta Pharmacol Sin; 2007 Nov; 28(11):1835-41. PubMed ID: 17959036
[TBL] [Abstract][Full Text] [Related]
28. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
29. Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.
Liu ZJ; Lu X; Zhang Y; Zhong S; Gu SZ; Zhang XB; Yang X; Xin HM
FEBS Lett; 2005 Mar; 579(7):1587-90. PubMed ID: 15757645
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
31. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
[TBL] [Abstract][Full Text] [Related]
33. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
34. Reduction of radiation-induced apoptosis by specific expression of Bcl-2 in normal cells.
Itamochi H; Yamasaki F; Sudo T; Takahashi T; Bartholomeusz C; Das S; Terakawa N; Ueno NT
Cancer Gene Ther; 2006 May; 13(5):451-9. PubMed ID: 16294215
[TBL] [Abstract][Full Text] [Related]
35. A promoter function of the CCCGGG Sma I recognition sequence and its specific role in determining p53 status and identifying DNA damaging agents.
Yang AL; Festing MF
Biochem Biophys Res Commun; 2001 Feb; 281(2):506-10. PubMed ID: 11181076
[TBL] [Abstract][Full Text] [Related]
36. Ipaf is upregulated by tumor necrosis factor-alpha in human leukemia cells.
Gutierrez O; Pipaon C; Fernandez-Luna JL
FEBS Lett; 2004 Jun; 568(1-3):79-82. PubMed ID: 15196924
[TBL] [Abstract][Full Text] [Related]
37. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
38. KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells.
Marreiros A; Dudgeon K; Dao V; Grimm MO; Czolij R; Crossley M; Jackson P
Oncogene; 2005 Jan; 24(4):637-49. PubMed ID: 15580298
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.
Yang C; Kaushal V; Haun RS; Seth R; Shah SV; Kaushal GP
Cell Death Differ; 2008 Mar; 15(3):530-44. PubMed ID: 18064040
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of hypoxia on etoposide-induced apoptosis according to the cancer cell lines.
Cosse JP; Sermeus A; Vannuvel K; Ninane N; Raes M; Michiels C
Mol Cancer; 2007 Sep; 6():61. PubMed ID: 17894897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
